Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan

BMC Infectious Diseases

Volumn 7, Issue , 2007, Pages

  Lee, Sai Cheong ^a,d   Huang, Shie Shian ^a,d   Lee, Chao Wei ^a   Fung, Chang Phone ^b,f   Lee, Ning ^a   Shieh, Wen Bin ^a,e   Siu, L K ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e CHANG GUNG UNIVERSITY   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; OXACILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; BETA LACTAM;

AEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATION; COMPARATIVE STUDY; DRUG POTENCY; ENTEROBACTERIACEAE; GRAM NEGATIVE FACULTATIVELY ANAEROBIC RODS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; QUALITY CONTROL; STAPHYLOCOCCUS AUREUS; TAIWAN; ADOLESCENT; ADULT; AGED; BACTERIAL INFECTION; BLOOD; CHILD; COMMUNICABLE DISEASE; DRUG EFFECT; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HUMAN; INFANT; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIA, AEROBIC; BETA-LACTAMS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; TAIWAN;

EID: 34548567450     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-7-79     Document Type: Article

References (22)

1. Fuchs PC Barry AL Brown SD In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers Antimicrob Agents Chemother 2001, 45:1915-1918. 90573 11353653 10.1128/AAC.45.6.1915-1918.2001
2. Livermore DM Carter MW Bagel S Wiedemann B Saquero F Loza E Endtz HP Nguyen J Nord CE Struelens MJ Nonhoff C Turnidage J Bell J Zbinden R Pfister S Mixson L Shungu DL In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia Antimicrob Agents Chemother 2001, 45:1860-1867. 90558 11353638 10.1128/ AAC.45.6.1860-1867.2001
3. Prous JR Fairley L Fleischer J Ertapenam: The first group 1 carbapenem Drugs Today 2005, 41:1-16. 16200218
4. Shah PM Isaacs RD Ertapenem, the first of a new group of carbapenems J Antimicrob Chemother 2003, 52:538-542. 10.1093/jac/dkg404 12951340
5. Livermore DM Sefton AM Scott GM Properties and potential of ertapenem J Antimicrob Chemother 2003, 52:331-344. 10.1093/jac/dkg375 12917243
6. Wexler HM In vitro activity of ertapenem: Review of recent studies J Antimicrob Chemother 2004, 53(Suppl S2):iI23-ii28.
7. Hilliard NJ Johnson CN Armstrong SH Quarles S Waites KB In vitro activity of ertapenem(MK-0826) against multi-drug resistant Streptococcus pneumoniae compared with 13 other antimicrobials Int J Antimicrob Agent 2002, 20:136-140. 10.1016/S0924-8579(02)00129-2
8. Livermore DM Oakton KJ Carter MW Warner M Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent-lactamases Antimicrob Agents Chemother 2001, 45:2831-2837. 90739 11557477 10.1128/ AAC.45.10.2831-2837.2001
9. Guillermo OR Caballero-Lopez J Friedland IR Gail LW Carides A Study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults Clin Infect Dis 2002, 34:1076-1083. 10.1086/339543 11914996
10. Goldstein EC Citron DM Merriam CV Warren Y Tyrrell KL Gesser RM General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam. Activity of ertapenem in skin infections Clin Infect Dis 2002, 35(Suppl 1):S119-S125. 10.1086/341932
11. Mandell LA Bartlett JG Dowell SF File TM Musher DM Whitney C Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Guidelines for CAP in adults Clin Infect Dis 2003, 37:1405-1433. 10.1086/380488 14614663
12. Lipsky BA Berendt AR Deery HG Embil JM Warren SJ Karchmer AW LeFrock JL Lew DP Mader JT Norden C Tan JS Diagnosis and Treatment of Diabetic Foot Infections. Guidelines for diabetic foot infections Clin Infect Dis 2004, 9:885-910. 10.1086/424846
13. Tellado J Woods GL Gesser R McCarroll K Teppler H Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections Surg Infect 2002, 3:303-314. 10.1089/109629602762539535
14. Alhambra A Cuadros JA Cacho J Gómez-Garcés JL Alós JI In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics J Antimicrob Chemother 2004, 53:1090-1094. 10.1093/jac/dkh218 15117925
15. Mazuki JE Sawyer RG Nathens AB Dipiro JT Schein M Kudsk KA Yowler C The surgical infection society guidelines on antimicrobial therapy for intra-abdominal infections Surg Infect 2002, 3:161-173. 10.1089/ 109629602761624171
16. Solomkin JS Mazuski JE Baron EJ Sawyer RG Nathens AB DiPiro JT Buchman T Dellinger EP Jernigan J Gorbach S Chow AW Bartlett J Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Treatment guidelines for intra-abdominal infections Clin Infect Dis 2003, 37:997-1005. 10.1086/378702 14523762
17. Tomera KM Burdmann EA Reyna OGP Jiang Q Wimmer WM Woods GL Richard M Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults Antimicrob Agents Chemother 2002, 46:2895-2900. 127417 12183244 10.1128/ AAC.46.9.2895-2900.2002
18. Wikler MA Low DE Cockerill FR Sheehan DJ Craig WA Tenover FC Dudley MN Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically:aPproved standard-seventh edition CLSI (formerly NCCLS) 2006:M7-A7.
19. Huang MB Gay TE Baker CN Bannerjee SN Tenover FC Two per cent sodium chloride is required for susceptibility testing of staphylococci with oxacillin when using agar-based dilution methods J Clin Microbiol 1993, 31:2683-2688. 265975 8253966
20. Tomasz A Drugeon HB de Lencastre HM Jabes D McDougal L Bille J New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding capacity Antimicrob Agents Chemother 1989, 33:1869-1874. 172779 2610497
21. Ubukata K Nakagami S Nitta A Yamane A Kawakami S Sugiura M Konno A Rapid detection of the mecA gene in methicillin-resistant staphylococci by enzymatic detection of polymerase chain reaction products Clin Microbiol 1992, 30(7):1728-1733.
22. Rybak MJ LaPente KL Community-associated methicillin-resistant Staphylococcus aureus: A review Pharmacother 2005, 25:74-85. 10.1592/phco.25.1.74.55620